ARCN1 and neoplasm: Therefore, the observed differential sensitivity of the normal fibroblasts and tumor cell lines to ARCN1 depletion, as well as the previously described sensitivity of non-small cell lung cancer cells bearing KRAS mutations39, is likely mediated by a different mechanism.